John Wiley & Sons (WLY) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
29 Dec, 2025Executive summary
Q3 and year-to-date results showed 1% adjusted revenue growth, driven by 5% growth in research and strong AI licensing, offsetting a 6% decline in Learning; nearly 75% of research revenue is recurring, with robust global R&D investment and early AI adoption.
Margin and cash flow improvement were driven by operational execution, cost re-engineering, and expanded AI content licensing agreements, with adjusted EPS up 39% and operating margin up 280bps to 14.2%.
Divestitures of non-core businesses led to a 12% decline in reported revenue, but core segments delivered growth and profitability.
Geographic diversification is strong, with Asia-Pacific accounting for 45% of article output and US federal funding representing a small portion of revenue.
Confident outlook for revenue, profit, and cash flow in Fiscal 2025 and 2026, with margin outlook raised for Fiscal 2026.
Financial highlights
Q3 adjusted revenue up 1% to $405M; adjusted EBITDA up 4% to $94M; adjusted EPS up 39% to $0.84; GAAP EPS loss of ($0.43) vs. ($2.08) prior year.
Nine-month adjusted revenue up 3% to $1,218M; adjusted EBITDA up 12% to $272M; adjusted EPS up 43% to $2.28.
Free cash flow for nine months at $44M, tracking ahead of prior year; full-year outlook reaffirmed at $125M.
$30M in AI licensing revenue generated year-to-date, with $9M from a Q3 research content deal.
Cost of sales and operating expenses declined significantly due to divestitures and restructuring.
Outlook and guidance
Fiscal 2025 revenue expected near midpoint of $1.65–1.69 billion, representing ~3% growth; adjusted EBITDA projected near midpoint of $385–410M, margin at high end of 23–24%.
Adjusted EPS expected at high end of $3.25–$3.60, up from $2.78 last year.
Free cash flow guidance reaffirmed at $125M, ~10% growth over prior year.
Fiscal 2026 margin target raised to above 25%, with free cash flow target reaffirmed at $200M.
Ongoing cost optimization and restructuring expected to yield $90M in annualized savings.
Latest events from John Wiley & Sons
- Q3 delivered margin gains, strong cash flow, and high-end guidance reaffirmation.WLY
Q3 20266 Mar 2026 - Strategic transformation, leadership change, and strong governance define this year's proxy.WLY
Proxy Filing3 Feb 2026 - FY2025 saw robust growth, board refreshment, and enhanced ESG, with key votes at the 2025 meeting.WLY
Proxy Filing3 Feb 2026 - Shareholders to vote on directors, auditor, and executive pay at the September 2025 meeting.WLY
Proxy Filing3 Feb 2026 - Annual meeting to vote on directors, auditor ratification, and executive pay on Sept 26, 2024.WLY
Proxy Filing3 Feb 2026 - Learning and GenAI deals drive margin expansion and positive FY25 growth outlook.WLY
Q4 20243 Feb 2026 - Adjusted revenue up 6%, EPS up 74%, with divestitures and GenAI content fueling growth.WLY
Q1 202522 Jan 2026 - Adjusted revenue up 3%, margin and EPS growth, AI progress, and guidance reaffirmed.WLY
Q2 202511 Jan 2026 - Research and AI growth drove margin gains, offsetting Learning declines and market headwinds.WLY
Q2 20267 Dec 2025